Propiedad y actividad de insiders de Mesa Laboratories, Inc. (MLAB): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $125.29 |
| Capitalización | $701M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-09 | Capone Mark Christopher | A-Award | 2,423 | |
| 2026-09-09 | Ladiwala Shiraz Shabanali | A-Award | 2,510 | |
| 2009-09-09 | Alltoft Jennifer Sadie | A-Award | 1,774 | |
| 2026-09-09 | Hall Shannon | A-Award | 1,774 | |
| 2026-09-09 | Sullivan John James | A-Award | 1,774 | |
| 2026-09-09 | Tripeny R Tony | A-Award | 1,774 | |
| 2026-08-15 | Capone Mark Christopher | M-Exempt | 2,784 | |
| 2026-08-15 | Capone Mark Christopher | M-Exempt | 2,784 | |
| 2026-08-15 | Alltoft Jennifer Sadie | M-Exempt | 2,784 | |
| 2026-08-15 | Alltoft Jennifer Sadie | M-Exempt | 2,784 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $5.8M | $5.5M | $10.2M | $81.4M | $263.9M | $49.3M | $32.9M | $28.2M | $27.3M | $26.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $14.3M | $14.3M | $12.5M | $21.1M | $23.8M | $41.2M | $42.6M | $39.1M | $42.0M | $44.1M |
| Inventario | $13.9M | $9.2M | $6.8M | $14.2M | $11.2M | $24.6M | $34.6M | $32.7M | $25.4M | $26.4M |
| Activos Corrientes | $35.8M | $32.0M | $33.6M | $122.8M | $303.7M | $124.3M | $119.0M | $109.4M | $102.7M | $106.3M |
| Inmovilizado Material | $26.0M | $23.6M | $22.2M | $22.1M | $22.0M | $28.6M | $28.1M | $41.4M | $32.3M | $48.1M |
| Fondo de Comercio | $72.2M | $65.5M | $66.4M | $141.5M | $160.8M | $291.2M | $286.4M | $180.1M | $181.8M | $186.9M |
| Activos Intangibles | $37.8M | $42.9M | $33.2M | $119.9M | $111.7M | $250.1M | $216.8M | $113.8M | $96.9M | $83.3M |
| Activos Totales | $171.7M | $164.1M | $156.8M | $420.2M | $601.5M | $707.4M | $661.8M | $446.8M | $433.3M | $427.7M |
| Cuentas por Pagar | $2.2M | $2.4M | $2.9M | $3.4M | $4.5M | $7.9M | $6.1M | $6.0M | $5.7M | $4.9M |
| Deuda a Corto | $1.1M | $1.6M | $2.1M | 0 | 0 | 0 | 0 | 0 | $101.0M | $5.6M |
| Pasivos Corrientes | $16.6M | $17.3M | $23.7M | $26.0M | $32.6M | $48.1M | $43.4M | $44.3M | $164.0M | $61.9M |
| Deuda a Largo | $53.7M | $44.6M | $20.6M | $140.3M | $145.7M | $218.4M | $183.3M | $221.7M | $76.9M | $145.9M |
| Pasivos Totales | $73.9M | $64.7M | $45.5M | $200.2M | $195.2M | $313.6M | $268.4M | $301.4M | $273.5M | $241.5M |
| Reservas | $73.7M | $68.3M | $73.3M | $71.9M | $72.5M | $76.7M | $74.2M | -$183.5M | -$188.9M | -$185.7M |
| Patrimonio Neto | $97.8M | $99.4M | $111.3M | $220.0M | $406.2M | $393.8M | $393.5M | $145.4M | $159.8M | $186.2M |
| Deuda Total | $54.8M | $46.3M | $22.7M | $141.4M | $146.7M | $221.1M | $186.1M | $231.3M | $181.5M | $168.8M |
| Deuda Neta | $49.0M | $40.8M | $12.6M | $60.0M | -$117.2M | $171.8M | $153.2M | $203.1M | $154.2M | $141.9M |
| Capital Circulante | $19.2M | $14.7M | $10.0M | $96.8M | $271.2M | $76.3M | $75.6M | $65.0M | -$61.3M | $44.4M |
Salud financiera
| Deuda / Patrimonio | 0.54 |
| Ratio corriente | 2.07 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 1.45 |
Rentabilidad
| Rentabilidad sobre capital | 2.59% |
| Rentabilidad sobre capital invertido | 3.05% |
| Rentabilidad sobre activos | 1.14% |
| Margen bruto | 65.99% |
| Margen operativo | 9.00% |
| Margen neto | 1.92% |
Empresas relacionadas: BZAI · EGAN · GDEV · GRRR · GRVY · LPTH · MVIS
Explorar sector: Healthcare · Medical - Specialties
Más secciones de MLAB: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones